Deutsche Bank
SGP

Deutsche Bank’s SpyGlass Pharma SGP Stock Holding History

Deutsche Bank’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
+10,962
New +$238K ﹤0.01% 3144

Other funds holding SGP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Deutsche Bank's SGP Position: Q2 2026 in Review

Deutsche Bank opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 10,962 shares worth $244K. The stake represents ﹤0.01% of the portfolio and ranks #3144 among its holdings.

14 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Deutsche Bank held 10,962 shares of SpyGlass Pharma worth $244K as of Q2 2026.
  • SpyGlass Pharma was a new Deutsche Bank position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3144 holding.
  • 14 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.